Literature DB >> 8769031

1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand.

.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8769031

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  21 in total

Review 1.  An update on the diagnosis of osteoporosis.

Authors:  J A Kanis
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

2.  Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods.

Authors:  C G Isles; L D Ritchie; P Murchie; J Norrie
Journal:  BMJ       Date:  2000-03-11

3.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

4.  Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs.

Authors:  R Neary; S Ramachandran
Journal:  BMJ       Date:  2000-07-15

5.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

6.  Dyslipidemia guidelines.

Authors:  Hugh R Hindle
Journal:  CMAJ       Date:  2004-07-20       Impact factor: 8.262

7.  99 mTc-MIBI washout as a complementary factor in the evaluation of idiopathic dilated cardiomyopathy (IDCM) using myocardial perfusion imaging.

Authors:  Mohammad Kazem Shiroodi; Babak Shafiei; Nastaran Baharfard; Mohammad Esmail Gheidari; Babak Nazari; Elaheh Pirayesh; Ali Kiasat; Samaneh Hoseinzadeh; Abolghassem Hashemi; Mohammad Ali Akbarzadeh; Hamid Javadi; Iraj Nabipour; Majid Assadi
Journal:  Int J Cardiovasc Imaging       Date:  2010-12-28       Impact factor: 2.357

Review 8.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

9.  New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.

Authors:  Michael Crooke
Journal:  Clin Biochem Rev       Date:  2007-02

Review 10.  Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials.

Authors:  F Liu; M Prabhakar; J Ju; H Long; H-W Zhou
Journal:  Eur J Clin Nutr       Date:  2016-09-14       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.